pioglitazone has been researched along with Child Behavior Disorders in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Child Behavior Disorders: Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the safety and efficacy of pioglitazone added to risperidone in the treatment of irritability in autistic disorder (AD), we conducted this study." | 9.20 | A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism. ( Akhondzadeh, S; Farokhnia, M; Ghaleiha, A; Mohammadi, MR; Nikoo, M; Rasa, SM, 2015) |
| "To assess the safety and efficacy of pioglitazone added to risperidone in the treatment of irritability in autistic disorder (AD), we conducted this study." | 5.20 | A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism. ( Akhondzadeh, S; Farokhnia, M; Ghaleiha, A; Mohammadi, MR; Nikoo, M; Rasa, SM, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghaleiha, A | 1 |
| Rasa, SM | 1 |
| Nikoo, M | 1 |
| Farokhnia, M | 1 |
| Mohammadi, MR | 1 |
| Akhondzadeh, S | 1 |
1 trial available for pioglitazone and Child Behavior Disorders
| Article | Year |
|---|---|
A pilot double-blind placebo-controlled trial of pioglitazone as adjunctive treatment to risperidone: Effects on aberrant behavior in children with autism.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Child Behavior Disorders; Child, Preschool; Double-B | 2015 |